National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 63031 [2021-24765]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 86, No. 217 / Monday, November 15, 2021 / Notices Name of Committee: Board of Scientific Counselors, NIEHS. Date: December 5–7, 2021. Closed: December 5, 2021, 4:00 p.m. to 5:00 p.m. Agenda: Discussion of BSC Reviews. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Open: December 6, 2021, 9:30 a.m. to 11:50 a.m. Agenda: Meeting Overview and Q & A Session. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Closed: December 6, 2021, 11:55 a.m. to 1:45 p.m. Agenda: Sessions with Investigators. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Open: December 6, 2021, 1:50 p.m. to 3:20 p.m. Agenda: Poster Session. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Closed: December 6, 2021, 3:35 p.m. to 5:00 p.m. Agenda: Sessions with Trainees and Staff Scientist. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Open: December 7, 2021, 10:00 a.m. to 11:50 a.m. Agenda: Q & A Session. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Closed: December 7, 2021, 11:55 a.m. to 5:00 p.m. Agenda: Sessions with Investigators. Place: National Institute of Environmental Health Science, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Virtual Meeting). Contact Person: Darryl C. Zeldin, Scientific Director & Principal Investigator, Division of Intramural Research, National Institute of Environmental Sciences, NIH, 111 T.W. Alexander Drive, Mail drop MSC A2–09, Research Triangle Park, NC 27709, 919–541– 1169, zeldin@niehs.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower VerDate Sep<11>2014 16:42 Nov 12, 2021 Jkt 256001 63031 Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: November 8, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings [FR Doc. 2021–24773 Filed 11–12–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Adjuvant Comparison and Characterization (N01). Date: December 7–8, 2021. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Disease, National Institutes of Health, 5601 Fishers Lane, Room 3G41, Rockville, MD 20892 (Virtual Meeting). Contact Person: Tara Capece, Ph.D., MPH, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G41, Rockville, MD 20852, 240–191–4281, capecet2@ niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 8, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–24765 Filed 11–12–21; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis, Panel Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed). Date: December 7–8, 2021. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dimitrios N. Vatakis, Ph.D. Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20852 301–761–7176, dimitrios.vatakis@ nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis, Panel Centers for AIDS Research (P30 Clinical Trial Not Allowed). Date: December 7–8, 2021. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dimitrios N. Vatakis, Ph.D. Scientific Review Officer, Scientific Review Program Division, of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20852 301–761–7176, dimitrios.vatakis@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 86, Number 217 (Monday, November 15, 2021)]
[Notices]
[Page 63031]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24765]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Adjuvant Comparison and 
Characterization (N01).
    Date: December 7-8, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Disease, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Tara Capece, Ph.D., MPH, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41, 
Rockville, MD 20852, 240-191-4281, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 8, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-24765 Filed 11-12-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.